SIGMA Brand
Displaying 91751-91800 of 96265 results.
| Sigma Cat.No. | Description |
|---|---|
| UPS1 | Universal Proteomics Standard Set Protein Mass Spectrometry Calibration Standard |
| UPS2 | Proteomics Dynamic Range Standard Set Protein Mass Spectrometry Calibration Standard |
| V0130 | [Arg8]-Vasotocin acetate salt ≥97% (HPLC) |
| V0132 | Vitronectin from rat plasma lyophilized powder, BioReagent, suitable for cell culture |
| V0377 | [Arg8]-Vasopressin solution Grade VI (synthetic), ~100 IU/mL in 0.9% NaCl |
| V0384 | cis-Vaccenic acid ≥97% (capillary GC), oil |
| V0389 | Anti-VGLUT1 antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution |
| V0513 | L-Valine from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0% |
| V0627 | Valinomycin ≥98% (TLC), ≥90% (HPLC) |
| V0631 | Vortex adapter for microcentrifuge tubes capacity, 8 tubes |
| V0756 | Vortex adapter for microcentrifuge tubes capacity, 20 tubes |
| V0882 | D-Val-Leu-Lys 4-nitroanilide dihydrochloride plasmin substrate |
| V1 | Vitamins Kit ~98% (Components, TLC) |
| V1005 | [deamino-Cys1, D-Arg8]-Vasopressin acetate salt hydrate ≥95% (HPLC) |
| V1007 | Vanderzant vitamin mixture for insects Animal-component free, BioReagent, suitable for insect cell culture |
| V1014 | Anti-Vascular Endothelial Growth Factor Receptor 2 antibody produced in goat affinity isolated antibody, lyophilized powder |
| V105 | S(−)-Verapamil hydrochloride hydrate ≥98% (HPLC), powder |
| V106 | R(+)-Verapamil monohydrochloride hydrate ≥98% (HPLC), powder |
| V108 | (±)-Norverapamil hydrochloride ≥98% (HPLC) |
| V113 | S(+)-γ-Vigabatrin solid |
| V1130 | Vancomycin hydrochloride from Streptomyces orientalis BioReagent, suitable for plant cell culture |
| V1131 | trans-Vaccenic acid ≥99% (capillary GC) |
| V116 | Z-VAD-FMK solid |
| V1253 | Anti-Vascular Endothelial Growth Factor antibody produced in goat affinity isolated antibody, lyophilized powder |
| V1255 | D-Valine BioReagent, suitable for cell culture |
| V1377 | Vinblastine sulfate salt 96-102% (HPLC) |
| V1381 | Methyl trans-vaccenate ≥99% (capillary GC), liquid |
| V1385 | VEGF Receptor-1 (Flt-1)/Fc Chimera human >90% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder |
| V1514 | Anti-VE-Cadherin (CD144) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution |
| V2002 | Vancomycin hydrochloride from Streptomyces orientalis ≥900 μg per mg (as vancomycin base) |
| V2010 | Viscozyme® L cellulolytic enzyme mixture |
| V2013 | [deamino-Cys1, Val4, D-Arg8]-Vasopressin ≥95% |
| V2255 | [β-Mercapto-β,β-cyclopentamethylenepropionyl1, O-me-Tyr2, Arg8]-Vasopressin ≥97% (HPLC) |
| V2258 | Monoclonal Anti-Vimentin antibody produced in mouse clone LN-6, ascites fluid |
| V2260 | Monoclonal Anti-V5-Peroxidase antibody produced in mouse clone V5-10, purified immunoglobulin, lyophilized powder |
| V2264 | Vinorelbine ditartrate salt hydrate ≥98% (HPLC), powder |
| V2501 | Snake venom from Vipera russelli (Russell’s Viper) |
| V2502 | Marine venom from Chrysaora quinquecirrha (Sea Nettle) lyophilized powder |
| V2503 | Val-Ala p-Nitroanilide acetate salt protease substrate |
| V2514 | Anti-VGLUT2 (HY-19) antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution |
| V2753 | Virginiamycin M1 ≥95% (HPLC) |
| V2876 | Vitamin B12 ≥98% |
| V2881 | Freezing vials, natural capacity 500 μL, skirted bottom, non-sterile |
| V2889 | Valeryl Salicylate ≥98% (HPLC) |
| V3003 | Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 (KDR) antibody produced in mouse clone 260.4, KDR-2, ascites fluid |
| V3135 | Greiner Cryo.s™ vials capacity 2 mL, natural cap, internal threads |
| V3254 | Vitamin B12-Agarose saline suspension |
| V3381 | Freezing vials, natural capacity 500 μL, skirted bottom, sterile |
| V3388 | Vascular Endothelial Growth Factor (aa 207-318) human ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder |
| V3501 | Vitamin K1 viscous liquid |